DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR GEMZAR

« Back to Dashboard

Clinical Trials for Gemzar

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00002998	Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer	Completed	National Cancer Institute (NCI)	Phase 2	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of gemcitabine and cisplatin in treating patients with metastatic breast cancer that has not responded to systemic therapy.
NCT00002998	Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer	Completed	Alliance for Clinical Trials in Oncology	Phase 2	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of gemcitabine and cisplatin in treating patients with metastatic breast cancer that has not responded to systemic therapy.
NCT00003182	Cisplatin and Gemcitabine in Treating Patients With Advanced Squamous Cell Cancer of the Head and Neck	Unknown status	Hope Cancer Institute, Inc.	Phase 1/Phase 2	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of cisplatin and gemcitabine in treating patients with advanced squamous cell cancer of the head and neck that cannot be surgically removed.
NCT00003925	Combination Chemotherapy In Treating Patients With Advanced Cancer	Completed	National Cancer Institute (NCI)	Phase 1	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of combining gemcitabine, fluorouracil-uracil and leucovorin in treating patients who have advanced cancer that has not responded to previous therapy.

Clinical Trial Conditions for Gemzar

Condition Name

Condition Name for Gemzar
Intervention	Trials
Pancreatic Cancer	26
Pancreatic Neoplasms	13
Breast Cancer	10
Metastatic Pancreatic Cancer	8

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Gemzar
Intervention	Trials
Pancreatic Neoplasms	59
Lung Neoplasms	22
Carcinoma, Non-Small-Cell Lung	22
Adenocarcinoma	21

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Gemzar

Trials by Country

Trials by Country for Gemzar
Location	Trials
United States	514
Italy	58
Germany	30
United Kingdom	25
Australia	23

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Gemzar
Location	Trials
Texas	36
Florida	27
New York	24
Minnesota	23
California	22

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Gemzar

Clinical Trial Phase

Clinical Trial Phase for Gemzar
Clinical Trial Phase	Trials
Phase 4	3
Phase 3	21
Phase 2/Phase 3	3

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Gemzar
Clinical Trial Phase	Trials
Completed	68
Recruiting	44
Terminated	17

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Gemzar

Sponsor Name

Sponsor Name for Gemzar
Sponsor	Trials
Eli Lilly and Company	24
National Cancer Institute (NCI)	19
Celgene Corporation	9

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Gemzar
Sponsor	Trials
Other	177
Industry	113
NIH	19

Export unavailable in trial.
Subscribe for complete access.